Absence of GluD2 Antibodies in Patients With Opsoclonus-Myoclonus Syndrome

OBJECTIVE: A recent study showed glutamate receptor delta 2 antibodies (GluD2-ab) in sera of patients with opsoclonus-myoclonus syndrome (OMS). Inconsistencies between cerebellar immunoreactivity and expression of GluD2 led us to hypothesize that these antibodies are not biomarkers of OMS. METHODS:...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neurology
Glavni autori: Petit-Pedrol, Mar, Guasp, Mar, Armangue, Thais, Lavarino, Cinzia, Morales La Madrid, Andres, Saiz, Albert, Graus, Francesc, Dalmau, Josep
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2021
Teme:
Null Hypothesis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8055333/
https://ncbi.nlm.nih.gov/pubmed/33443132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000011410
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items